2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition

AAA ATPase conformational high jinks The protein p97 is an AAA adenosine triphosphatase (ATPase) that uses energy from ATP hydrolysis to regulate substrates involved in intracellular protein quality control. Its role in this central process makes it a target for cancer chemotherapy. Banerjee et al. used cryo-electron microscopy to determine high-resolution structures for multiple conformational states of this dynamic macromolecular machine. They also determined the structure of the ADP-bound state bound to an inhibitor. The structures give insight into nucleotide-driven structural changes that drive function and show how inhibitor binding prevents these conformational changes Science, this issue p. 871 Cryo–electron microscopy reveals atomic-resolution structures of a protein complex that is a target for cancer drug development. p97 is a hexameric AAA+ adenosine triphosphatase (ATPase) that is an attractive target for cancer drug development. We report cryo–electron microscopy (cryo-EM) structures for adenosine diphosphate (ADP)–bound, full-length, hexameric wild-type p97 in the presence and absence of an allosteric inhibitor at resolutions of 2.3 and 2.4 angstroms, respectively. We also report cryo-EM structures (at resolutions of ~3.3, 3.2, and 3.3 angstroms, respectively) for three distinct, coexisting functional states of p97 with occupancies of zero, one, or two molecules of adenosine 5′-O-(3-thiotriphosphate) (ATPγS) per protomer. A large corkscrew-like change in molecular architecture, coupled with upward displacement of the N-terminal domain, is observed only when ATPγS is bound to both the D1 and D2 domains of the protomer. These cryo-EM structures establish the sequence of nucleotide-driven structural changes in p97 at atomic resolution. They also enable elucidation of the binding mode of an allosteric small-molecule inhibitor to p97 and illustrate how inhibitor binding at the interface between the D1 and D2 domains prevents propagation of the conformational changes necessary for p97 function.

[1]  T. Nilsson,et al.  Cytosolic ATPases, p97 and NSF, are sufficient to mediate rapid membrane fusion , 1999, The EMBO journal.

[2]  M van Heel,et al.  Structure of the AAA ATPase p97. , 2000, Molecular cell.

[3]  A. Wilkinson,et al.  AAA+ superfamily ATPases: common structure–diverse function , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[4]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[5]  Hisao Kondo,et al.  Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47 , 2004, The EMBO journal.

[6]  P. Hanson,et al.  AAA+ proteins: have engine, will work , 2005, Nature Reviews Molecular Cell Biology.

[7]  R. Isaacson,et al.  Conformational changes in the AAA ATPase p97–p47 adaptor complex , 2006, The EMBO journal.

[8]  W. Weis,et al.  Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change. , 2008, Structure.

[9]  Randy J Read,et al.  Automated structure solution with the PHENIX suite. , 2008, Methods in molecular biology.

[10]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[11]  L. Esser,et al.  A novel ATP‐dependent conformation in p97 N–D1 fragment revealed by crystal structures of disease‐related mutants , 2010, The EMBO journal.

[12]  R. Deshaies,et al.  Development of p97 AAA ATPase inhibitors , 2011, Autophagy.

[13]  N. Vij,et al.  Critical Role of VCP/p97 in the Pathogenesis and Progression of Non-Small Cell Lung Carcinoma , 2011, PloS one.

[14]  Steven J Brown,et al.  Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways , 2011, Proceedings of the National Academy of Sciences.

[15]  H. Schindelin,et al.  Hierarchical binding of cofactors to the AAA ATPase p97. , 2011, Structure.

[16]  W. Chia,et al.  ATP Binding to p97/VCP D1 Domain Regulates Selective Recruitment of Adaptors to Its Proximal N-Domain , 2012, PloS one.

[17]  B. le Bail,et al.  Sorafenib-Mediated Targeting of the AAA+ ATPase p97/VCP Leads to Disruption of the Secretory Pathway, Endoplasmic Reticulum Stress, and Hepatocellular Cancer Cell Death , 2012, Molecular Cancer Therapeutics.

[18]  P. Freemont,et al.  The Role of the N-Domain in the ATPase Activity of the Mammalian AAA ATPase p97/VCP , 2012, The Journal of Biological Chemistry.

[19]  A. Isacchi,et al.  Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. , 2013, Nature chemical biology.

[20]  D. Xia,et al.  Altered Intersubunit Communication Is the Molecular Basis for Functional Defects of Pathogenic p97 Mutants* , 2013, The Journal of Biological Chemistry.

[21]  R. Deshaies,et al.  Structure–Activity Relationship Study Reveals ML240 and ML241 as Potent and Selective Inhibitors of p97 ATPase , 2013, ChemMedChem.

[22]  T. Ando,et al.  High-speed atomic force microscopic observation of ATP-dependent rotation of the AAA+ chaperone p97. , 2013, Structure.

[23]  A. Isacchi,et al.  Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships. , 2013, Journal of medicinal chemistry.

[24]  P. Freemont,et al.  Inter-ring rotations of AAA ATPase p97 revealed by electron cryomicroscopy , 2014, Open Biology.

[25]  S. Suh,et al.  Structural Basis for Ovarian Tumor Domain-containing Protein 1 (OTU1) Binding to p97/Valosin-containing Protein (VCP)* , 2014, The Journal of Biological Chemistry.

[26]  Correction to Palladium-Catalyzed Aerobic Oxidative Cyclization of N-Aryl Imines: Indole Synthesis from Anilines and Ketones , 2014 .

[27]  Hemant D. Tagare,et al.  The Local Resolution of Cryo-EM Density Maps , 2013, Nature Methods.

[28]  H. Meyer,et al.  The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis , 2014, Journal of Cell Science.

[29]  Henry J. Lin,et al.  Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains. , 2014, Journal of molecular biology.

[30]  R. Deshaies,et al.  Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy , 2014, BMC Biology.

[31]  Abstract DDT02-01: Inhibition of the AAA-ATPase p97 with the first in class inhibitor CB-5083 as a novel approach to treat cancer , 2015 .

[32]  P. Wipf,et al.  Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97. , 2015, ACS medicinal chemistry letters.

[33]  A. Bartesaghi,et al.  2.2 Å resolution cryo-EM structure of β-galactosidase in complex with a cell-permeant inhibitor , 2015, Science.

[34]  J. L. La Clair,et al.  Inhibitors of the AAA+ Chaperone p97 , 2015, Molecules.

[35]  Henry J. Lin,et al.  Evaluating p97 Inhibitor Analogues for Their Domain Selectivity and Potency against the p97–p47 Complex , 2015, ChemMedChem.

[36]  A Fragment-Based Ligand Screen Against Part of a Large Protein Machine , 2015, Journal of biomolecular screening.

[37]  J. Flammer,et al.  Mitochondrial function in neuronal cells depends on p97/VCP/Cdc48-mediated quality control , 2015, Front. Cell. Neurosci..

[38]  M. K. Lemberg,et al.  Clipping or Extracting: Two Ways to Membrane Protein Degradation. , 2015, Trends in cell biology.

[39]  Ana Luísa Carvalho,et al.  SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97. , 2015, Biochimica et biophysica acta.

[40]  Donna D. Zhang,et al.  Withaferin A Analogs That Target the AAA+ Chaperone p97. , 2015, ACS chemical biology.

[41]  R. Sauer,et al.  Origin and Functional Evolution of the Cdc48/p97/VCP AAA+ Protein Unfolding and Remodeling Machine. , 2015, Journal of molecular biology.